Deciphera Pharmaceuticals (DCPH)
(Delayed Data from NSDQ)
$25.37 USD
0.00 (0.00%)
Updated May 9, 2024 04:00 PM ET
After-Market: $25.38 +0.01 (0.04%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth B Momentum C VGM
Price, Consensus and EPS Surprise
DCPH 25.37 0.00(0.00%)
Will DCPH be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for DCPH based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for DCPH
AnaptysBio, Inc. (ANAB) Reports Q1 Loss, Tops Revenue Estimates
The Zacks Analyst Blog Highlights Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine
DCPH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Biotech Stock Roundup: GILD's GSK' Q1 Earnings, DCPH Soars on Acquisition News & More
Alnylam Pharmaceuticals (ALNY) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Deciphera Pharmaceuticals, Inc. (DCPH) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Other News for DCPH
Analysts Offer Insights on Healthcare Companies: Alignment Healthcare (ALHC), Butterfly Network (BFLY) and Deciphera Pharmaceuticals (DCPH)
Wall Street Breakfast: The Week Ahead
Catalyst Watch: Disney earnings, Apple iPad event and Fed speakers back on the circuit
Biotech Alert: Searches spiking for these stocks today
Deciphera Pharmaceuticals Reaches Analyst Target Price